Experts explain why access to specialty cancer care, open dialogue, and patient education are essential to building trust and making informed treatment decisions.
|Articles|June 29, 2012
Healthcare Decision: What Happens Now?
Advertisement
The Supreme Court’s decision to uphold all but one provision in the Affordable Care Act means that for now, at least, one of the most far-reaching overhauls of the nation’s health-care system will be the law of the land. New rules for insurers that have taken effect will remain in place, while new opportunities to gain health-care coverage will begin in 2014.
Read the full story:
Source: The Washington Post
Advertisement
Related to this article
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches.
Rosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.
Hidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place.
Advertisement
Advertisement
Trending on AJMC
1
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV
2
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
3
New Mechanism of DME Treatment Highlights Clinical Trial Updates
4
Using Complement Inhibitors in GA Comes With Pros and Cons
5